Clinical Trials
3 trialsNCT01594723 2025-07-23
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Eli Lilly and Company
Phase 2 Active not recruiting
NCT01134120 2018-04-17
A Study in Myeloproliferative Disorders
Eli Lilly and Company
Phase 1 Completed
NCT01520220 2017-04-12
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
Eli Lilly and Company
Phase 1 Completed